{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:19:36Z","timestamp":1787026776622,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Bacopa monnieri (BM), a commonly used herb, has shown neuroprotective effects in animal and\n                      <jats:italic>in vitro<\/jats:italic>\n                      studies; but human studies on patients with Alzheimer\u2019s Disease (AD) have been inconclusive. Further high-quality trials are required to conclusively state the utility of BM in AD and other neurodegenerative dementias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the present study, we did a narrative review of the current challenges in designing clinical trials of BM in dementia and their evidence-based recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Many facets of the BM trials need improvement, especially effect size and sample size estimation. Current assessment and outcomes measures need a more holistic approach and newer scales for diagnosing and monitoring prodromal AD. The stringent guidelines in CONSORT and STROBE are often considered difficult to implement for clinical trials in ayurvedic medications like BM. However, adherence to these guidelines will undoubtedly improve the quality of evidence and go a long way in assessing whether BM is efficacious in treating AD\/prodromal AD patients and other neurodegenerative dementias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Future studies on BM should implement more randomized controlled trials (RCTs) with an appropriate sample size of accurately diagnosed AD\/prodromal AD patients, administering a recommended dosage of BM and for a pre-specified time calculated to achieve adequate power for the study. Researchers should also develop and validate more sensitive cognitive scales, especially for prodromal AD. BM should be evaluated in accordance with the same rigorous standards as conventional drugs to generate the best quality evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2023.1134775","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:27:00Z","timestamp":1677634020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Importance of high-quality evidence regarding the use of Bacopa monnieri in dementia"],"prefix":"10.3389","volume":"15","author":[{"given":"Ayush","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswamohan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Vasantha Padma","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venugopalan Y.","family":"Vishnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"B1","year":"2017","journal-title":"Alzheimer\u2019s Disease Neuroimaging Initiative."},{"key":"B2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-2011-0062","article-title":"Power calculations for clinical trials in Alzheimer\u2019s disease.","author":"Ard","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1002\/ptr.7203","article-title":"Bacosides from Bacopa monnieri extract: an overview of the effects on neurological disorders.","volume":"35","author":"Banerjee","year":"2021","journal-title":"Phytother. Res."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2196\/38542","article-title":"Bacopa monnieri in the treatment of dementia due to Alzheimer\u2019s disease: a systematic review of randomised controlled trials.","volume":"11","author":"Basheer","year":"2022","journal-title":"Interact. J. Med. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0944-7113(96)80041-9","article-title":"Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies.","volume":"2","author":"Bauer","year":"1996","journal-title":"Phytomed. Int J Phytother Phytopharm."},{"key":"B6","year":"2023","journal-title":"Double Blind."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80045-2","article-title":"The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data.","volume":"11","author":"Brimson","year":"2021","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000475900","article-title":"Neurocognitive effect of nootropic drug brahmi (Bacopa monnieri) in Alzheimer\u2019s disease.","volume":"24","author":"Chaudhari","year":"2017","journal-title":"Ann. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.14283\/jpad.2016.110","article-title":"Short-term impact of a combined Nutraceutical on cognitive function, perceived stress and depression in young elderly with cognitive impairment: a pilot, double-blind, randomized clinical trial.","volume":"4","author":"Cicero","year":"2017","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology.","volume":"11","author":"\u010colovi\u0107","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"B11","year":"2011","journal-title":"Alzheimer\u2019s Disease and Dementia."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7010","article-title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study.","volume":"7","author":"Egger","year":"2003","journal-title":"Health Technol. Assess Winch Engl."},{"key":"B13","article-title":"Clinical Investigation of Medicines for the Treatment Alzheimer\u2019s Disease - Scientific Guideline. European Medicines Agency","year":"2018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","article-title":"What makes clinical research ethical?","volume":"283","author":"Emanuel","year":"2000","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1098\/rstb.2010.0384","article-title":"The placebo response in clinical trials: more questions than answers.","volume":"366","author":"Enck","year":"2011","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-397928-5.00016-7","article-title":"Chapter 16 - balanced placebo design, active placebos, and other design features for identifying, minimizing and characterizing the placebo response","author":"Enck","year":"2013","journal-title":"Placebo and Pain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.7326\/0003-4819-144-5-200603070-00013","article-title":"Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.","volume":"144","author":"Gagnier","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"B18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3736\/jcim20121002","article-title":"Facts about standardization of herbal medicine: a review.","volume":"10","author":"Garg","year":"2012","journal-title":"Zhong Xi Yi Jie He Xue Bao."},{"key":"B19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jaim.2021.06.012","article-title":"RCTs and other clinical trial designs in Ayurveda: a review of challenges and opportunities.","volume":"12","author":"Gautama","year":"2021","journal-title":"J. Ayurveda Integr. Med."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0973-8258.62156","article-title":"A review on Bacopa monniera: current research and future prospects.","volume":"4","author":"Gohil","year":"2010","journal-title":"Int. J. Green Pharm."},{"key":"B21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/2229-3485.106383","article-title":"Placebo in clinical trials.","volume":"4","author":"Gupta","year":"2013","journal-title":"Perspect. Clin. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/2229-3485.106383","article-title":"A test of the systems analysis underlying the scientific theory of Ayurveda\u2019s Tridosha.","volume":"11","author":"Hankey","year":"2005","journal-title":"J. Altern. Complement Med. N. Y. N."},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1089\/acm.2005.11.385","article-title":"Performance-based and observational assessments in clinical trials across the Alzheimer\u2019s disease spectrum.","volume":"14","author":"Harvey","year":"2017","journal-title":"Innov. Clin. Neurosci."},{"key":"B24","year":"2022","journal-title":"Confessions of an Ayurveda Professor."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.20529\/IJME.2022.049","article-title":"Commentary: is the placebo effect actually increasing over time?","volume":"25","author":"Jeste","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry Off. J. Am. Assoc. Geriatr. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jagp.2017.04.010","article-title":"The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?","volume":"136","author":"Kaptchuk","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-11-200206040-00011","article-title":"Systematic overview of Bacopa monnieri (L.) Wettst. dominant poly-herbal formulas in children and adolescents.","volume":"4","author":"Kean","year":"2017","journal-title":"Medicines"},{"key":"B28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/medicines4040086","article-title":"Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.","volume":"151","author":"Kongkeaw","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jep.2013.11.008","article-title":"Standardization of herbal medicines - a review.","volume":"4","author":"Kunle","year":"2012","journal-title":"Int. J. Biodivers. Conserv."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.5897\/IJBC11.163","article-title":"Dementia prevention, intervention, and care.","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Cognitive composite score association with Alzheimer\u2019s disease plaque and tangle pathology.","volume":"10","author":"Malek-Ahmadi","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13195-018-0401-z","article-title":"Adoption of the double dummy trial design to reduce observer bias in testing treatments.","volume":"106","author":"Maru\u0161i\u0107","year":"2013","journal-title":"J. R. Soc. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0141076813485350","article-title":"Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer\u2019s disease.","volume":"24","author":"McEvoy","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/WAD.0b013e3181d1b814","article-title":"Ethical issues concerning research in complementary and alternative medicine.","volume":"291","author":"Miller","year":"2004","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jama.291.5.599","article-title":"The Alzheimer\u2019s disease assessment scale: an instrument for assessing treatment efficacy.","volume":"19","author":"Mohs","year":"1983","journal-title":"Psychopharmacol. Bull."},{"key":"B36","year":"2016","journal-title":"Paying for Complementary and Integrative Health Approaches."},{"key":"B37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.phymed.2007.03.010","article-title":"Safety evaluation of BacoMind? in healthy volunteers: a phase I study.","volume":"14","author":"Pravina","year":"2007","journal-title":"Phytomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.phymed.2007.03.010","article-title":"Late-onset Alzheimer disease.","volume":"25","author":"Rabinovici","year":"2019","journal-title":"Contin. Minneap. Minn."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000700","article-title":"Geophila repens phytosome-loaded intranasal gel with improved nasal permeation for the effective treatment of Alzheimer\u2019s disease.","volume":"69","author":"Rajamma","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jddst.2021.103087","article-title":"Building bridges between Ayurveda and modern science.","volume":"1","author":"Rastogi","year":"2010","journal-title":"Int. J. Ayurveda Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/0974-7788.59943","article-title":"Why and how? Addressing to the two most pertinent questions about pharmacovigilance in Ayurveda.","volume":"2","author":"Rastogi","year":"2011","journal-title":"Int. J. Ayurveda Res."},{"key":"B42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12664-018-0883-4","article-title":"Safety in Ayurveda: Need to bring the house in order.","volume":"37","author":"Rastogi","year":"2018","journal-title":"Indian J. Gastroenterol. Off. J. Indian Soc. Gastroenterol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jceh.2021.08.006","article-title":"Herbal immune booster-induced liver injury in the COVID-19 pandemic - a cautious interpretation is desired before any generalization is attempted.","volume":"12","author":"Rastogi","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jceh.2021.08.006","article-title":"Recommended cognitive outcomes in preclinical Alzheimer\u2019s disease: consensus statement from the European prevention of Alzheimer\u2019s dementia project.","volume":"13","author":"Ritchie","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.07.154","article-title":"Research diagnostic criteria for Alzheimer\u2019s disease: findings from the LipiDiDiet randomized controlled trial.","volume":"13","author":"Rosenberg","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13195-021-00799-3","article-title":"Immunologically mediated dementias.","volume":"9","author":"Rosenbloom","year":"2009","journal-title":"Curr. Neurol. Neurosci .Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11910-009-0053-2","author":"Sagers","year":"2010","journal-title":"Significant Interactions With the Most Commonly Used Herbal and Nonherbal Supplements Impact Warfarin Safety and Efficacy."},{"key":"B48","first-page":"359","article-title":"Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi).","volume":"29","author":"Singh","year":"1997","journal-title":"Indian J. Pharmacol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-536X.2002.00149.x","article-title":"Acupuncture to treat nausea and vomiting in early pregnancy: a randomized controlled trial.","volume":"29","author":"Smith","year":"2002","journal-title":"Birth Berkeley Calif."},{"key":"B50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ctim.2019.03.016","article-title":"Neuropharmacological and cognitive effects of Bacopa monnieri (L.) Wettst \u2013 A review on its mechanistic aspects.","volume":"44","author":"Sukumaran","year":"2019","journal-title":"Complement The.r Med."},{"key":"B51","year":"2021","journal-title":"Making Ayurveda a real science."},{"key":"B52","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00415-010-5616-2","article-title":"Complementary and alternative medicine use among US adults with common neurological conditions.","volume":"257","author":"Wells","year":"2010","journal-title":"J. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1134775\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:27:10Z","timestamp":1677634030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1134775\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":52,"alternative-id":["10.3389\/fnagi.2023.1134775"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1134775","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"1134775"}}